SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Idenix Pharmaceuticals (IDIX) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (405)4/15/2011 12:14:48 PM
From: tuck  Read Replies (2) | Respond to of 412
 
With its clinical candidates dead except for 184, which is single in an HCV marketplace in which marriage will be rewarded, and good candidates are already taken, IDIX seems ready for the death spiral. Novartis' continued participation in financings has propped up the stock, and I have taken that gift to boot this out of my Mom's portfolio this morning for a small loss.

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News